News

robotic systems cath lab stents navigation systems corindus corpath one

Corindus Vascular Robotics, a provider of precision medical robotics, announced the launch of its CorPath One Stent Program.

A new study demonstrated that some patients may not need to receive prolonged anti-clotting therapy after drug-...

tryton stent, bifurcation stenting

clinical trial designed to measure the effectiveness of using a dedicated side branch-covering bare metal...

Promus Element, Boston Scientific, Promus Element stent, drug-eluting stent

In the first head-to-head randomized controlled trial of third-generation durable-polymer drug-eluting stents for the treatment of coronary artery disease in an all-comers patient population, the...

A new study showed that a conservative approach to revascularization for patients with intermediate coronary...

stents biforcation clinical trial study cath lab tryton tct side branch

Tryton Medical Inc., a developer of stents designed to treat bifurcation lesions, announced activities...

xience prime xpedition V antiplatelet stents eluting clinical trial study cath

Abbott announced it plans to initiate a randomized, controlled trial in the United States to evaluate the use...

stents bioresorbable fortitude amaranth

Amaranth Medical, a privately held medical device company, presented positive six-month angiographic results from its first-in-human study including patients undergoing percutaneous...

balloon catheters stents clinical trial study orbusneich scoreflex journal

OrbusNeich announced the publication of a study demonstrating that lesion preparation with the company’s...

biotronik orsiro stents drug-eluting cinical trial bioflow

Biotronik Japan announced enrollment of the first patient in the Bioflow-IV study, which aims to verify the efficacy...

stents drug eluting biosensors tct 2012 transcatheter biomatrix neoflex spectrum

Biosensors International’s expanded product portfolio offers physicians a broader range of treatment options to improve patient outcomes.

October 23, 2013 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

stents peripheral artery disease pad devices fda lifestent solo vascular bard

Bard Peripheral Vascular has sent an urgent Class I medical device recall notification letter informing customers of the problems of the LifeStent Solo ...

stents peripheral atherectomy devices artery disease PAD covidien everflex

Covidien released positive final results from its Durability II study and promising preliminary data from its Definitive AR trial at the Vascular Interventional Advances (VIVA) 2013 conference in...

boston scientific stents peripheral clinical trial study innova des drug-eluting

Launching a clinical trial expected to serve as the foundation for global regulatory approvals, a physician in...

cath lab stents ostial accessclosure flash system dual balloon angioplasty

AccessClosure Inc. announced an exclusive agreement with Ostial Corp. to distribute the Flash Ostial System Dual Balloon Angioplasty ...

Micell Technologies Inc. announced that a peer reviewed article discussing imaging and clinical results of the...